000 | 01187 a2200289 4500 | ||
---|---|---|---|
005 | 20250513103631.0 | ||
264 | 0 | _c19970207 | |
008 | 199702s 0 0 eng d | ||
022 | _a1076-1551 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClĂ ria, J | |
245 | 0 | 0 |
_aAspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. _h[electronic resource] |
260 |
_bMolecular medicine (Cambridge, Mass.) _cSep 1996 |
||
300 |
_a583-96 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
650 | 0 | 4 |
_aAspirin _xpharmacology |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyeicosatetraenoic Acids _xbiosynthesis |
650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
650 | 0 | 4 |
_aNeutrophils _xcytology |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aLee, M H | |
700 | 1 | _aSerhan, C N | |
773 | 0 |
_tMolecular medicine (Cambridge, Mass.) _gvol. 2 _gno. 5 _gp. 583-96 |
|
999 |
_c8890961 _d8890961 |